Chongdeng L. Shi

State Key Laboratory Of Discovery And Utilization Of Functional Components In Traditional Chinese Medicine, Shandong Key Laboratory Of Targeted Drug Delivery And Advanced Pharmaceutics, Shandong Basic Science Special Academic Zone And Key Laboratory Of Chemical Biology, 
Jinan, CN 
State Key Laboratory Of Discovery And Utilization Of Functional Components In Traditional Chinese Medicine, Shandong Key Laboratory Of Targeted Drug Delivery And Advanced Pharmaceutics, Shandong Basic Science Special Academic Zone And Key Laboratory Of Chemical Biology, 
Jinan, CN 

Overview

Chongdeng Shi practices practicing medicine in Jinan, China.

Their clinical expertise encompasses Multiple Sclerosis (MS), Listeriosis, and Glioma.

They are actively involved in clinical research, co-authoring 19 peer reviewed articles.

Locations

State Key Laboratory Of Discovery And Utilization Of Functional Components In Traditional Chinese Medicine, Shandong Key Laboratory Of Targeted Drug Delivery And Advanced Pharmaceutics, Shandong Basic Science Special Academic Zone And Key Laboratory Of Chemical Biology, Jinan, 250012, China
Other Locations
State Key Laboratory Of Discovery And Utilization Of Functional Components In Traditional Chinese Medicine, Shandong Key Laboratory Of Targeted Drug Delivery And Advanced Pharmaceutics, NMPA Key Laboratory For Clinical Research And Evaluation Of Innovative Drug, NMPA Key Laboratory For Technology Research And Evaluation Of Drug Products And Key Laboratory Of Chemical Biology, 44 Cultural West Road, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

19 Total Publications

In situ generation of EBNA1 CAR-T cells eradicates antigen specific auto-immune B cells for multiple sclerosis treatment.
In situ generation of EBNA1 CAR-T cells eradicates antigen specific auto-immune B cells for multiple sclerosis treatment.
Journal: Acta pharmaceutica Sinica. B
Published: August 27, 2025

Frequently Asked Questions about Chongdeng L. Shi

Is Chongdeng L. Shi a top-rated expert for Multiple Sclerosis (MS)?

MediFind is an objective health platform that identifies experts based on real-world data. Chongdeng L. Shi is classified as an Experienced expert for Multiple Sclerosis (MS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Chongdeng L. Shi participate in research or clinical trials?

Yes. Chongdeng L. Shi has published 19 articles and abstracts on conditions like Multiple Sclerosis (MS). You can view a list of Chongdeng L. Shi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Shi's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile